Payer Sciences

Overview

Payer Sciences is a Publicis Health market access agency that combines payer analytics, access strategy, and payer/HCP communications under one engagement. Best-fit buyers are manufacturers that need payer segmentation, access-scenario modeling, and pull-through materials connected in a single agency relationship rather than split across a strategy boutique and a creative shop.

Payer Sciences is not a top-of-house pricing/GTN consultancy or a standalone software platform. The proprietary tools (VOLT, PTO, AMP, AIM, PAR, n1Connect) are agency assets that produce outputs for account teams; treat them as agency deliverables, not as licensable SaaS.

Market Access Capability Model

The framework below standardizes how Rx Almanac evaluates market-access-consulting capabilities, so buyers can compare vendors like-for-like while the readout column stays vendor-specific. For this table, Payer Sciences is evaluated as Publicis Health market access agency that combines payer analytics, access strategy, and payer/HCP communications under one engagement.

Capability	Buyer should compare	Payer Sciences readout
Payer landscape and access strategy	Payer segmentation, formulary expectations, coverage barriers, benefit design, and access scenario planning.	Core. Public positioning centers on payer/prescriber behavior data shaping access strategy.
Pricing, contracting, and GTN strategy	WAC strategy, rebate design, contracting scenarios, GTN forecasting, channel economics, and net-price risk.	Adjacent. VOLT-style access-scenario modeling supports value discussions; confirm whether contracting, rebate, and GTN modeling is delivered directly or with partner specialists.
HEOR, value dossiers, and evidence planning	Budget impact, cost-effectiveness, AMCP dossier, evidence gaps, PRO endpoints, and value story.	Adjacent. Supports value-story and payer-message work; not a substitute for a dedicated HEOR/RWE consultancy.
Payer engagement and message testing	Ad boards, mock P&T, payer research, message testing, objection handling, and stakeholder mapping.	Core. Agency model is built for payer insight generation, message testing, and translating insights into access communications.
Policy, IRA, Medicaid, and channel strategy	IRA, Medicaid, 340B, Medicare, specialty channel, distribution, and policy-risk implications.	Confirm policy strategy in the RFP. Ask: which policy/IRA/Medicaid case studies has the named team led in the past 24 months.
Launch sequencing and execution support	Cross-functional launch planning, access playbooks, field tools, governance, and implementation support.	Core, agency-led. Publicis Health resources can scale execution; confirm the Payer Sciences team owns the access workstream end-to-end.

Buyer Fit

• Procurement trigger: Launch teams that need payer analytics, access strategy, and payer/HCP communications from one agency relationship rather than three vendors.
• Best-fit buyers: Mid-sized to large pharma; specialty launches where pull-through and account-team enablement materials matter as much as the underlying strategy.
• Less ideal fit: Buyers seeking pure pricing/GTN consulting, dedicated HEOR/RWE work, or a standalone software license without agency services.
• Commercial fit: Custom/RFP with agency retainer plus project SOWs; expect Publicis-network change-order patterns.
• Decision checks: Which Publicis Health capabilities are inside the Payer Sciences scope, and which need a separate sibling-agency SOW.

Differentiators

• Analytics-plus-communications under one agency: Few payer-strategy boutiques can also produce account-team materials and HCP campaigns; few pure agencies can match the payer-data fluency.
• Proprietary tool stack (VOLT, PTO, AMP, AIM, PAR, n1Connect): Diligence the live demos, outputs, integrations, and account-team adoption rather than the tool names.
• Publicis Health ecosystem: Access to creative, media, data, and technology siblings; map which capabilities sit inside Payer Sciences vs. require Publicis sibling agencies.
• Access-scenario modeling orientation: Strongest where payer coverage, formulary position, account sequencing, and pull-through need to be modeled before launch.
• Payer/prescriber communications fluency: More differentiated as an analytics-informed access-communications partner than as a pure formulary-data vendor.

RFP Questions

• Which payer inputs are primary research, standing panels, claims/formulary data, or consultant judgment?
• Which outputs are generated by VOLT, PTO, AMP, AIM, PAR, or n1Connect, and which are agency deliverables built around those tools?
• What evidence shows account teams, field reimbursement, or payer marketers actually use the tool outputs after launch?
• How will pricing, contracting, evidence, and access communications be reconciled into one launch plan?
• Which Publicis Health capabilities are included in the Payer Sciences scope, and which require a separate Publicis agency or SOW?
• Which team members are the senior operators on the work, and what launch analogs have they handled?
• How are change orders, pass-through costs, and Publicis-network rate-card terms governed?

Recent Activity

• 2024 - MM+M Agency 100 coverage reported approximately $32M in revenue, 78 employees, and 7% growth.
• 2024-2026 - No Payer Sciences-specific public acquisition, platform launch, or partnership announcement is captured in the current public record; treat recency, referenceability, and launch-resource availability as diligence items.